Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2005-09-26

Original market date: See footnote 1

2000-01-25

Product name:

LYTEPREP

DIN:

02239569 Electronic product monograph is not available

Company:

THERAPEX DIVISION DE E-Z-EM CANADA INC
11065 Boul. L.-H. Lafontaine
Ville D'Anjou
Quebec
Canada H1J 2Z4

Class:

Human

Dosage form(s):

Powder

Route(s) of administration:

Oral

Number of active ingredient(s):

5

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

56:12.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

A06AD10 MINERAL SALTS IN COMBINATION

Active ingredient group (AIG) number:See footnote5

0524479004

List of active ingredient(s)
Active ingredient(s) Strength
POLYETHYLENE GLYCOL 3350 236 G / BOTTLE
POTASSIUM CHLORIDE 2.97 G / BOTTLE
SODIUM BICARBONATE 6.74 G / BOTTLE
SODIUM CHLORIDE 5.86 G / BOTTLE
SODIUM SULFATE 22.74 G / BOTTLE
Version 4.0.2
Date modified: